✦ LIBER ✦

Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals

✍ Scribed by Andrabi, Raiees; Williams, Constance; Wang, Xiao-Hong; Li, Liuzhe; Choudhary, Alok K.; Wig, Naveet; Biswas, Ashutosh; Luthra, Kalpana; Nadas, Arthur; Seaman, Michael S.; Nyambi, Phillipe; Zolla-Pazner, Susan; Gorny, Miroslaw K.

Book ID: 120154197
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 188 KB
Volume: 439
Category: Article
ISSN: 0042-6822
DOI: 10.1016/j.virol.2012.12.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of human anti-V3 monocl

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor

✍ Andrabi, Raiees; Makhdoomi, Muzamil; Luthra, Kalpana 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 79 KB

Production and characterization of human

Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors

✍ Raiees Andrabi, Rajesh Kumar, Manju Bala, Ambili Nair, Ashutosh Biswas, Naveet W 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 718 KB

Identification and characterization of s

Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A–H) and group O primary HIV-1 isolates

✍ Els Beirnaert; Phillipe Nyambi; Betty Willems; Leo Heyndrickx; Robert Colebunder 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

A previous study on cross-clade neutralization activity, identified three key isolates, MNlab (envB/gagB; X4 coreceptor), VI525 (envG/gagH, envA/gagA; R5X4) and CA9 (Group O; R5), that allowed discrimination of sera, likely or unlikely to neutralize primary HIV-1 isolates belonging to Group M (env c